Philogen
Not specified, CH · 1 known investors
Philogen discovers and develops targeted anti-cancer biopharmaceutical drugs using monoclonal antibodies and small molecules for tumor-specific delivery. The company focuses on vascular targeting to deliver therapeutic agents to tumors while sparing healthy tissues.
Investors · 1
In the news
Frequently asked questions
- What does Philogen do?
- Philogen discovers and develops targeted anti-cancer biopharmaceutical drugs using monoclonal antibodies and small molecules for tumor-specific delivery. The company focuses on vascular targeting to deliver therapeutic agents to tumors while sparing healthy tissues.
- Who are Philogen's investors?
- Philogen's investors include NovaCapital.
- Where is Philogen headquartered?
- Philogen is headquartered in Not specified, CH.